[Treatment of a subcapsular renal bleeding after extracorporeal shockwave lithotripsy with recombinant, activated factor VII].
We report on a patient who suffered a large subcapsular and perirenal haematoma after extracorporeal shockwave lithotripsy. Despite surgical intervention the bleeding did not stop for 6 days and 10 units of packed red blood cells were transfused. With the treatment of recombinant, activated factor VIII (NovoSeven((R))) an immediate haemostasis could be reached, so that impending nephrectomy could be avoided. This is the first case where FVIIa has been successfully used to stop a trauma-related bleeding in a patient without any obvious accompanying coagulation disorder.
Langer
H
H
Abteilung für Anästhesiologie, Klinikum Coburg gGmbH, Germany. Haraldlanger@t-online.de
Strohmaier
W L
WL
Probst
S
S
D001803:Blood Transfusion; D004322:Drainage; D017707:Erythrocyte Transfusion; D005167:Factor VII / Q000627:therapeutic use*; D006406:Hematoma / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D006487:Hemostasis; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D008096:Lithotripsy / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D005167:Factor VII